1. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
2. What ethical criteria should be followed for medical drug promotion?
3. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
4. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
5. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
6. Under what conditions can the aid from the research fund be withdrawn and a clinical trial terminated?
7. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
8. When does an Inspector need to divide a sample into three portoons instead of four?
9. What authority is responsible for inspecting and regulaying the manufacturing of drugs under 1976 rules?
10. Who is responsible for carrying out the audit of the Authority's accounts?
11. What is the age requirement for the Chief Executive Officer (CEO) of the Authority?
12. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
13. What is the main duty of a Federal Inspector?
14. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
15. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
16. What is the purpose of a separate application for manufacturing drugs on more than one set of premises?
17. What form should be used for applying for the grant or renewal of a licence to manufacture drugs?
18. For drugs other than those falling under specific categories, whose approval is required for the specifications?
19. What is the role of the Appellate Board under The Drug Regulatory Authority of Pakistan Act, 2012?
20. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
21. What does the term "Advertise" mean under Schedule-II?
22. What is the commencement date for the Drugs (Specifications) Rules, 1978?
23. Who may physically inspect an imported consignment, draw samples, and order the importer not to sell or dispose of the drug for a specific period?
24. What is the purpose of the Committee on Drugs Evaluation?
25. What does an Inspector require from a person during a search or seizure under Schedule-V?
26. Which Division is responsible for the evaluation, assessment, and registration of pharmaceutical drugs for human beings and animals?
27. Which type of ophthalmic preparations is allowed to have a preservative?
28. What is the duration of a license to import drugs, unless suspended or canceled?
29. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
30. What is the purpose of the license to manufacture drugs for experimental purposes?
31. The Authority shall levy and collect fees for its functions at rates determined by:
32. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
33. What is the role of the Quality Control Department in the manufacturing process?
34. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
35. What is the primary purpose of the Committee of Experts on Drug Research?
36. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
37. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
38. What are "Medical Devices" under Schedule-I?
39. What is the maximum duration for which the approval of an advertisement under sub-rule (1) is valid?
40. What is the purpose of Form 10 in the export of drugs?
41. What must be included in the labelling and promotion of a registered drug?
42. What is the maximum duration of a licence issued under Drugs Licensing, Registering & Advertising rules 1976?
43. What condition must be met for a drug or substance to be advertised through press without reference to the Federal Government?
44. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
45. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
46. What is the purpose of an "airlock" in pharmaceutical manufacturing?
47. Which of the following substances would NOT be considered a "Medicated Cosmetic"?
48. Within what time frame should the Authority submit its annual report to the Federal Government?
49. How often must records of quarterly production and disposal of a drug be supplied to the Chairman of the Registration Board?
50. What action should the Authority take in response to objections raised by the Auditor-General?
51. What substances are NOT included in the definition of "Drug" under Schedule-I?
52. What are "Medical Devices" under Schedule-I?
53. What substances are NOT included in the definition of "Drug" under Schedule-I?
54. What does the term "batch number (or lot number)" refer to?
55. What is the penalty for giving a false warranty in respect of any therapeutic good or applying a warranty given for another therapeutic good?
56. What action should the Authority take in response to objections raised by the Auditor-General?
57. Who serves as the ex-officio Chairman of the Appellate Board?
58. What is the term of office for members of the Registration Board?
59. What information should be included in the written contract between the contract giver and contract acceptor for contract manufacture?
60. Which term refers to the set of operations that establish the relationship between values indicated by an instrument and known reference standards?
61. In what situations can a drug or substance be advertised to the medical, pharmaceutical, and allied professions without referring to the Federal Government?
62. Which authority is responsible for issuing licences to manufacture drugs by way of repacking under section 18 of ordinance in a province?
63. What are "Medicated Cosmetics" under Schedule-I?
64. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
65. Under what condition can finished drugs be imported?
66. What is the definition of "Biological Drugs (Ready-to-fill form)" under Schedule-I?
67. Within what time frame should the Authority submit its annual report to the Federal Government?
68. What is the definition of "promotion" for the purposes of Schedule G of 1976 Rules?
69. Which authority may authorize a Federal Inspector to disclose information acquired during official duties?
70. What is the purpose of the Drugs (Research) Rules, 1978?
71. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
72. What stage of investigation on human beings involves determining safety, effectiveness, and common side effects of a drug?
73. Under what conditions are drug advertisements to the general public generally permitted?
74. What is the primary function of the Federal Drug Laboratory as stated in the rules?
75. What is the penalty for a person who fails to provide information requested by the Authority?
76. The Authority may open its accounts with:
77. What type of containers are ophthalmic solutions and suspensions required to be contained in?
78. Which of the following is NOT considered as "Therapeutic goods" under the Act?
79. What is the purpose of Schedule-III of the DRAP Act?
80. Who can revoke an order passed under Section 32 of the DRAP Act, 2012?
81. What is the maximum allowable retailer's discount for drugs?
82. What kind of offense is non-cognizable under the Drugs Act 1976?
83. Under what conditions is contract manufacture permissible?
84. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
85. When a Federal Inspector is not competent to take action under Schedule-IV, what should he do?
86. Who is considered an "investigator" under the Drugs (Research) Rules?
87. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
88. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
89. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
90. What is the penalty for a person who fails to provide information requested by the Authority?
91. The Central Research Fund fee collected by the Authority will be utilized for:
92. What is the fee for submitting an appeal to the Appellate Board, as mentioned in the rules?
93. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
94. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
95. In what type of premises should the manufacturing of drugs by way of basic or semi-basic manufacture take place?
96. Which of the following criteria should promotional claims about drugs adhere to?
97. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
98. Who qualifies as a Federal Inspector according to these rules?
99. Who is responsible for maintaining records of quarterly production and disposal of a drug?
100. What is the maximum quantity of a single drug that can be imported for personal use without exceeding the limit?
